EXOGENOUS NGF AFFECTS CHOLINERGIC TRANSMITTER FUNCTION AND Y-MAZE BEHAVIOR IN AGED FISCHER 344 MALE-RATS

被引:39
作者
WILLIAMS, LR
RYLETT, RJ
MOISES, HC
TANG, AH
机构
[1] UNIV WESTERN ONTARIO,DEPT PHYSIOL,LONDON N6A 3K7,ONTARIO,CANADA
[2] ROBARTS RES INST,LONDON,ENGLAND
[3] UNIV MICHIGAN,DEPT PHYSIOL,ANN ARBOR,MI 48109
关键词
D O I
10.1017/S0317167100032546
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Chronic ICV administration of NGF stimulates the activity of the cholinergic neuronal markers, HACU and ChAT, as well as the evoked release of both endogenous and newly synthesized acetylcholine in the brain of aging Fischer 344 male rats. However, the pattern of cholinergic phenotype stimulation indicates an age-related differential regulation of ChAT, HACU, and ACh release between specific brain areas, with the largest effects found in the striatum. NGF treatment also increases the effectiveness of neurotransmission between basal forebrain cholinergic neurons and postsynaptic amygdaloid target neurons. The stimulation of central cholinergic transmitter function after NGF treatment affects behavior in a Y-maze brightness discrimination paradigm. NGF treatment does not affect the cognitive measure of brightness discrimination, but reduces the number of avoidance attempts, a measure of motor function.
引用
收藏
页码:403 / 407
页数:5
相关论文
共 17 条
[1]   CHOLINERGIC MECHANISMS AND ALTERATIONS IN BEHAVIORAL SUPPRESSION AS FACTORS PRODUCING TIME-DEPENDENT CHANGES IN AVOIDANCE PERFORMANCE [J].
ANISMAN, H .
JOURNAL OF COMPARATIVE AND PHYSIOLOGICAL PSYCHOLOGY, 1973, 83 (03) :465-477
[2]   AMELIORATION OF CHOLINERGIC NEURON ATROPHY AND SPATIAL MEMORY IMPAIRMENT IN AGED RATS BY NERVE GROWTH-FACTOR [J].
FISCHER, W ;
WICTORIN, K ;
BJORKLUND, A ;
WILLIAMS, LR ;
VARON, S ;
GAGE, FH .
NATURE, 1987, 329 (6134) :65-68
[3]   INTRACEREBROVENTRICULAR BETHANECHOL CHLORIDE INFUSION IN ALZHEIMERS-DISEASE - RESULTS OF A COLLABORATIVE DOUBLE-BLIND-STUDY [J].
HARBAUGH, RE ;
REEDER, TM ;
SENTER, HJ ;
KNOPMAN, DS ;
BASKIN, DS ;
PIROZZOLO, F ;
CHUI, HC ;
SHETTER, AG ;
BAKAY, RAE ;
LEBLANC, R ;
WATSON, RT ;
DEKOSKY, ST ;
SCHMITT, FA ;
READ, SL ;
JOHNSTON, JT .
JOURNAL OF NEUROSURGERY, 1989, 71 (04) :481-486
[4]   NERVE GROWTH-FACTOR AND ALZHEIMERS-DISEASE [J].
HEFTI, F ;
WEINER, WJ .
ANNALS OF NEUROLOGY, 1986, 20 (03) :275-281
[5]   APPLICATION TO MAMMALIAN-TISSUES OF THE CHEMI-LUMINESCENT METHOD FOR DETECTING ACETYLCHOLINE [J].
ISRAEL, M ;
LESBATS, B .
JOURNAL OF NEUROCHEMISTRY, 1982, 39 (01) :248-250
[6]   ALZHEIMERS-DISEASE [J].
KATZMAN, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (15) :964-973
[7]   SPATIAL-LEARNING IN RATS - CORRELATION WITH CORTICAL CHOLINE-ACETYLTRANSFERASE AND IMPROVEMENT WITH NGF FOLLOWING NBM DAMAGE [J].
MANDEL, RJ ;
GAGE, FH ;
THAL, LJ .
EXPERIMENTAL NEUROLOGY, 1989, 104 (03) :208-217
[8]   CORRELATIONS BETWEEN NA+-K+ ATPASE ACTIVITY AND ACETYLCHOLINE-RELEASE IN RAT CORTICAL SYNAPTOSOMES [J].
MEYER, EM ;
COOPER, JR .
JOURNAL OF NEUROCHEMISTRY, 1981, 36 (02) :467-475
[9]   POTENTIAL USE OF NERVE GROWTH-FACTOR TO TREAT ALZHEIMERS-DISEASE [J].
PHELPS, CH ;
GAGE, FH ;
GROWDON, JH ;
HEFTI, F ;
HARBAUGH, R ;
JOHNSTON, MV ;
KHACHATURIAN, ZS ;
MOBLEY, WC ;
PRICE, DL ;
RASKIND, M ;
SIMPKINS, J ;
THAL, LJ ;
WOODCOCK, J .
NEUROBIOLOGY OF AGING, 1989, 10 (02) :205-207
[10]  
TANG AH, 1983, J PHARMACOL EXP THER, V225, P503